P228 THE PORTRAIT OF THE HYPERTENSIVE PATIENT: THE REALITY OF A NORTHERN PORTUGUESE SUBPOPULATION IN THE CONTEXT OF PRIMARY CARE

Background and Objectives: Hypertension is a chronic disease, and is one of the main cardiovascular risk factors. Knowing the local reality, regarding the comorbidities of the hypertensive population, profile of pharmacological therapy and level of blood pressure control are fundamental for the design of management and treatment strategies for hypertensive disease. In Portugal, hypertension has a estimated prevalence of 26,78% and the overwhelming majority of patients are assisted in primary care, where the health professionals have software tools such as BI-CSP, which uses Microsoft's Power-BI platform, allowing the retrieval of data about different variables. The aim of this study is to characterize a subpopulation studied at the Fânzeres Primary Care Center regarding demographic data, morbidity, blood pressure control and antihypertensive medication. Methods: This is an observational and cross-sectional descriptive study with an analytic component. The population consists of patients diagnosed with hypertension (N=3474). The retrieval of data was carried out using the MIMUF and BI-CSP. Results: In the population from which the 3474 hypertensive patients were selected, hypertension has a prevalence of 26%. The most common cardiovascular comorbidities were dyslipidemia (50%), Obesity (30%) and Diabetes (33%). 63% of patients had a systolic blood pressure (SBP) of <140mmHg and 28% had a SBP <130mmHg on the last measurement. Regarding the antihypertensives prescribed on a 4 month period, molecules that act on the renin-angiotensin axis are the main class used corresponding to 583K DDD (defined daily dose), followed by thiazides (300K DDD) and calcium channel blockers (250K DDD). Conclusions: There is still suboptimal control of hypertension in the population studied, which implies the adoption of more effective treatment strategies. It is important not only to involve adapting pharmacological treatment to the most recent guidelines, but also promote healthy lifestyles, control comorbidities and improve the follow-up of these patients. A multidisciplinary approach, using face-to-face and remote methods to strengthen contact with the healthcare team, can help to achieve these goals.